Showing 381-390 of 9526 results for "".
DermWireTV: Staff Vaccinations, Dupilumab Data, Rosacea Resource, Sensitive Skin Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-staff-vaccinations-dupilumab-data-rosacea-resource-sensitive-skin-week/19907/Most physicians have had a chance to be vaccinated, but staff may be a different story. Some practices are struggling with policies for mandated staff vaccines. The National Rosacea Society has updated its most popular educational booklet, “Understanding Rosacea.” New data highlight the potential imScientifically Speaking: When Accidents Happen in the Surgical/Aesthetic Clinic
https://practicaldermatology.com/topics/practice-management/scientifically-speaking-when-accidents-happen-in-the-surgicalaesthetic-clinic/19906/Surgical and laser procedures bring risks for infections, ocular injury, scarring, and more. In the second of a 2-part series, experts discuss best practices for managing adverse reactions with an emphasis on early intervention. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JDThe Secret Sauce of Business Success During COVID-19
https://practicaldermatology.com/topics/practice-management/the-secret-sauce-of-business-success-during-covid-19/23424/How to run an efficient and successful business for the long run.Mentorship Matters: Set the Pace for Long-term Success
https://practicaldermatology.com/topics/practice-management/mentorship-matters-set-the-pace-for-long-term-success/23406/Mentoring is one free strategy to building a better team. Here’s how a small but busy practice builds and develops its team and community through mentoring.DERM2020 Exhibitor Reaction: Sam Widdicombe, Almirall
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-exhibitor-reaction-sam-widdicombe-almirall/19843/Sam Widdicombe of Almirall, a DERM2020 exhibitor, tells us what she thinks of the conference and has a few positive messages for her team.Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReCustomized Care: Offering Patients the Best Treatment for Their Unique Situation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/customized-care-offering-patients-the-best-treatment-for-their-unique-situation/23261/While Mohs surgery boasts the highest cure rates for NMSC, dermatologists should be up to date on all options, including SRT.Special Report: COVID-19 Impact and Response
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-impact-and-response/19752/The COVID-19 pandemic is causing a halt in elective surgeries and forcing dermatology and aesthetics practices to temporarily close. Hear from those affected. Telemedicine is expanding in response to patient needs, as OCR addresses HIPAA enforcement. Learn about enforcement and new technology optionThe Pitfalls of Excessive Electronic Communication: “I Didn’t See That Email”
https://practicaldermatology.com/topics/practice-management/the-pitfalls-of-excessive-electronic-communication-i-didnt-see-that-email/23132/All communication should be thoughtful and intentional. Where does technology fit in?DermWireTV: Noble Educates on Self-Injection; AAD and DEF Meeting Updates
https://practicaldermatology.com/topics/practice-management/dermwiretv-noble-educates-on-self-injection-aad-and-def-meeting-updates/19645/Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended to increase patient confidence and autonomy with self-managed tre